""
www.streetinvesting.com: SIGA Technologies Inc. Under Current Review
Friday February 02, 2007 03:41:49 EST
In recent months, the Company has announced steady progress in both clinical development and receipt of government commitments to further fund the development of SIGA-246. In the clinic, the drug successfully completed its initial human safety trial. In a primate trial, the drug demonstrated complete prevention of smallpox disease. In two additional primate trials, SIGA-246 afforded complete protection against the monkeypox virus, a closely related disease that is even more virulent in that species. SIGA has also announced the receipt of over $20 million in additional grants from the National Institutes of Health to fund future SIGA-246 activities and advances in other drug programs ""
When/if the fda approves the new drug stock will jump big. I like the fact they have gov't funding I suppose.
Disclaimer : I do own have shares or SIGA, and you should do your own research. It is your money ; )
$3.87 (02/02/07)
